16 February 2016 - Canadian provinces may have slammed the door on what many have called the costliest medications in the world, breaking off negotiations with drug maker Alexion for the treatment of a rare genetic disorder that can cause kidney failure and threatens death in patients.

For more details, go to: http://www.lfpress.com/2016/02/16/negotiations-with-drug-maker-alexion-over-soliris-have-been-called-off-by-provinces